These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31568605)

  • 1. A proof-of-concept study on the effects of low total cfDNA content and solutions to increase the NIPT trisomy 21 detection rate.
    Du Y; Chen A; Yang R; Zhou T; Zhou Q; Yang L; Wang J; Hong Y; Chen C; Wan Q; Yang L; Chen Y
    J Clin Lab Anal; 2020 Feb; 34(2):e23035. PubMed ID: 31568605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of cell-free DNA testing for common fetal trisomies in triplet pregnancies.
    Zakaria H; Kleinfinger P; Lohmann L; Costa JM; Tsatsaris V; Salomon LJ; Jouannic JM; Rosenblatt J; Demain A; Benachi A; El Khattabi L; Vivanti AJ
    Prenat Diagn; 2024 May; 44(5):555-561. PubMed ID: 38448008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology.
    Gormus U; Chaubey A; Shenoy S; Wong YW; Chan LY; Choo BP; Oraha L; Gousseva A; Persson F; Prensky L; Chin E; Hegde M
    Curr Issues Mol Biol; 2021 Aug; 43(2):958-964. PubMed ID: 34449543
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study.
    Sánchez-Durán MÁ; Bernabeu García A; Calero I; Ramis Fossas J; Illescas T; Avilés MT; Maiz N; Carreras E
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):274. PubMed ID: 31370808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies.
    Huang T; Gibbons C; Rashid S; Priston MK; Bedford HM; Mak-Tam E; Meschino WS
    BMC Pregnancy Childbirth; 2020 Nov; 20(1):713. PubMed ID: 33228595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contingent cfDNA Screening Implementation: Increasing Diagnostic Accuracy and Reducing Invasive Testing - 6 Years' Results in a Single Center.
    Cubo AM; Huélamo M; Martín-Seisdedos MC; Hernández-Hernández E; Lapresa-Alcalde MV; Rodríguez-Martín MO; Doyague MJ; Sayagués JM
    Fetal Diagn Ther; 2022; 49(3):103-113. PubMed ID: 35259749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis.
    Gil MM; Accurti V; Santacruz B; Plana MN; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):302-314. PubMed ID: 28397325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enrichment of fetal and maternal long cell-free DNA fragments from maternal plasma following DNA repair.
    Vong JSL; Jiang P; Cheng SH; Lee WS; Tsang JCH; Leung TY; Chan KCA; Chiu RWK; Lo YMD
    Prenat Diagn; 2019 Jan; 39(2):88-99. PubMed ID: 30575063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
    Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
    DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome.
    Xiao G; Zhao Y; Huang W; Hu L; Wang G; Luo H
    PLoS One; 2022; 17(4):e0266718. PubMed ID: 35421148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing.
    Gordevičius J; Narmontė M; Gibas P; Kvederavičiūtė K; Tomkutė V; Paluoja P; Krjutškov K; Salumets A; Kriukienė E
    Clin Epigenetics; 2020 Oct; 12(1):153. PubMed ID: 33081811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dPCR-NIPT assay for detections of trisomies 21, 18 and 13 in a single-tube reaction-could it replace serum biochemical tests as a primary maternal plasma screening tool?
    Dai P; Yang Y; Zhao G; Gu Z; Ren H; Hu S; Liu N; Jiao W; Li J; Kong X
    J Transl Med; 2022 Jun; 20(1):269. PubMed ID: 35706031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
    Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-free DNA for Down syndrome screening in obese women: Is it a cost-effective strategy?
    Hopkins MK; Dugoff L; Durnwald C; Havrilesky LJ; Dotters-Katz S
    Prenat Diagn; 2020 Jan; 40(2):173-178. PubMed ID: 31803969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal screening for fetal trisomies using microarray-based cell-free DNA testing: A systematic review and meta-analysis.
    Geppert J; Stinton C; Johnson S; Clarke A; Grammatopoulos D; Taylor-Phillips S
    Prenat Diagn; 2020 Mar; 40(4):454-462. PubMed ID: 31834626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis.
    Gil MM; Galeva S; Jani J; Konstantinidou L; Akolekar R; Plana MN; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):734-742. PubMed ID: 31165549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.